BCIRG 007: Serum HER2 levels in women with metastatic HER2-amplified breast cancer

被引：0

作者：

Sampson, E. L.

Valero, V.

Roche, H.

Pienkowski, T.

Canon, J.

Zhao, Y.

Carney, W.

Mackey, J.

Taupin, H.

Lindsay, M.

Buyse, M.

Slamon, D.

机构：

[1] Siemens Med Solut Diagnost, Tarrytown, NY USA

[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA

[3] Inst Claudius Regaud, Toulouse, France

[4] MS Curie Mem Canc Ctr, Warsaw, Poland

[5] CH Notre Dame, Charleroi, Belgium

[6] Univ Calif Los Angeles, Los Angeles, CA USA

[7] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada

[8] CIRG, Paris, France

[9] CIRG, Edmonton, AB, Canada

[10] IDDI, Louvain, Belgium

来源：

CLINICAL CHEMISTRY | 2007年 / 53卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

A109

引用

页码：A34 / A34

页数：1

共 50 条

[41] Effective treatment of HER2-amplified breast cancer by targeting HER3 and β1 integrin [J].

Marcia R. Campbell ;

Hui Zhang ;

Shabnam Ziaee ;

Ana Ruiz-Saenz ;

Nathaniel Gulizia ;

Julie Oeffinger ;

Dhara N. Amin ;

Deepika Ahuja ;

Mark M. Moasser ;

Catherine C. Park .

Breast Cancer Research and Treatment, 2016, 155 :431-440

[42] A central role for HER3 in HER2-amplified breast cancer:: implications for targeted therapy [J].

Lee-Hoeflich, Si Tuen ;

Crocker, Lisa ;

Yao, Evelyn ;

Pham, Thinh ;

Munroe, Xander ;

Hoeflich, Klaus P. ;

Sliwkowski, Mark X. ;

Stern, Howard M. .

CANCER RESEARCH, 2008, 68 (14) :5878-5887

[43] Efficacy of HER2 inhibitors in metastatic breast cancer by discordance in HER2 amplification status between primary and metastatic breast cancer [J].

Van Raemdonck, E. ;

Berteloot, P. ;

Laenen, A. ;

Han, S. ;

Van Nieuwenhuysen, E. ;

Salihi, R. ;

Concin, N. ;

Vergote, I. ;

Floris, G. ;

Wildiers, H. ;

Punie, K. ;

Neven, P. .

CANCER RESEARCH, 2019, 79 (04)

[44] Targeting HER2 in patients with HER2-negative metastatic breast cancer with elevated serum levels of the HER2 extracellular domain and/or HER2-positive circulating tumor cells in the clinical routine [J].

Kurbacher, C. M. ;

Quade, A. ;

Kunstmann, G. ;

Herz, S. ;

Kurbacher, J. A. ;

Warm, M. A. .

ANNALS OF ONCOLOGY, 2015, 26

[45] Combinatorial therapies of neratinib for HER2-amplified cancer [J].

Zhao, Ming ;

Scott, Stephen ;

Evans, Kurt ;

Yuca, Erkan ;

Saridogan, Turcin ;

Demirhan, Mehmet E. ;

Kirby, Bryce P. ;

Kopetz, Scott ;

Diala, Irmina ;

Lalani, Alshad S. ;

Piha-Paul, Sarina A. ;

Meric-Bernstam, Funda .

MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)

[46] Effective treatment of HER2-amplified breast cancer by targeting HER3 and β1 integrin [J].

Campbell, Marcia R. ;

Zhang, Hui ;

Ziaee, Shabnam ;

Ruiz-Saenz, Ana ;

Gulizia, Nathaniel ;

Oeffinger, Julie ;

Amin, Dhara N. ;

Ahuja, Deepika ;

Moasser, Mark M. ;

Park, Catherine C. .

BREAST CANCER RESEARCH AND TREATMENT, 2016, 155 (03) :431-440

[47] Primary systemic therapy in HER2-amplified breast cancer: a clinical review [J].

Khasraw, Mustafa ;

Bell, Richard .

EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (08) :1005-1013

[48] Genetic testing in a cohort of young patients with HER2-amplified breast cancer [J].

Eccles, D. M. ;

Li, N. ;

Handwerker, R. ;

Maishman, T. ;

Copson, E. R. ;

Durcan, L. T. ;

Gerty, S. M. ;

Jones, L. ;

Evans, D. G. ;

Haywood, L. ;

Campbell, I. .

ANNALS OF ONCOLOGY, 2016, 27 (03) :467-473

[49] Correlation of trastuzumab treatment benefit with quantitative HER2 expression levels in HER2 positive metastatic breast cancer. [J].

Bachmeier, Beatrice ;

Sperinde, Jeff ;

Weidler, Jodi Marie ;

Lie, Yolanda ;

Chenna, Ahmed ;

Winslow, John ;

Engel, Jutta ;

Schubert-Fritschle, Gabriele ;

Sommerhoff, Christian ;

Petropoulos, Christos J. ;

Bates, Michael Patrick ;

Huang, Weidong ;

Nerlich, Andreas .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)

[50] Role of serum HER2 (sHER2) levels to predict acquisition of HER2 overexpression in patients with metastatic lesions of breast cancer with HER2-negative/unknown at the primary site [J].

Ribeiro, J. T. M. L. ;

Ali, S. M. ;

Correia, L. ;

Luis, I. M. V. D. ;

Matias, M. ;

Amaral, T. ;

Quintela, A. A. F. G. ;

Leitzel, K. ;

Lipton, A. ;

Costa, L. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)

← 1 2 3 4 5 →